Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€19.30

€19.30

-0.730%
-0.14
-0.730%
-
 
05.06.26 / Tradegate WKN: 854607 / Symbol: FUJIF / Name: Fujifilm / Stock / Office Equipment / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Fujifilm Holdings Corp. Stock

Fujifilm Holdings Corp. shows a slight decrease today, losing -€0.140 (-0.730%) compared to yesterday.

Pros and Cons of Fujifilm Holdings Corp. in the next few years

Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Fujifilm Holdings Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Fujifilm Holdings Corp. -0.730% 8.063% 21.920% 1.552% 5.928% -67.020% -66.271%
Canon Inc. -2.780% 4.304% 6.598% -8.619% -5.454% 0.636% 22.771%
Seiko Epson Corp. -0.520% -2.348% 32.103% 36.195% 42.500% 3.986% 6.875%
Ricoh Co. Ltd 0.000% 3.205% 15.000% 3.871% 8.784% -1.829% -22.596%

Comments

Buy Fujifilm Holdings Corp.
Show more

News

Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End
Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End

Key Points

Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End

Alvotech (NASDAQ:ALVO) Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparing to resubmit three biologics